Caliper Technologies - CALP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caliper Technologies - CALP

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mts362 who started this subject	4/4/2002 9:35:00 AM
From: nigel bates	Read Replies (1) of 114

Mike Pavia, chief technology officer for Millennium Pharmaceuticals, has joined the board of microfluidics company BioProcessors. BioProcessors, based in Woburn, Mass., is developing a microfluidic platform to allow for major parallel cell culture with the ability to simultaneously vary environmental parameters such as temperature, pH, and media conditions. The technology is designed to speed cell-based screening and pre-ADME evaluation. The company was founded in October 2000. (From Genomeweb) bioprocessors.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next